Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering Proventil to be added as reference list drug for generic albuterol MDIs.

Executive Summary

GENERIC ALBUTEROL MDI PRODUCTS MAY SEEK EQUIVALENCE TO SCHERING's PROVENTIL, FDA ruled in a Sept. 9 response to a Lachman Consultant Services petition to include Proventil as a reference for generic albuterol metered-dose inhalers ("The Pink Sheet" June 17, T&G-17). In granting the petition, submitted by former Office of Generic Drugs Program Support Staff Chief Robert Pollock, the agency states that it "will designate Proventil, in addition to [Glaxo Wellcome's] Ventolin, as a reference listed drug" in the "Orange Book."
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028908

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel